Rule, Reynaville C.
HRN: 25-68-54 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/07/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/07/2025
02/08/2025
IV
500
Q8
PROM X 1 Hr, Thickly Msaf
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes